| SC 13G/A | 2024-04-05 | BlackRock Inc. | Arcturus Therapeutics Holdings Inc. | 2,743,002 | 10.2% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Arcturus Therapeutics Holdings Inc. | 1,458,380 | 5.5% | EDGAR |
| SC 13G/A | 2024-02-12 | Nikko Asset Management Americas, Inc. | Arcturus Therapeutics Holdings Inc. | 1,320,652 | 4.9% | EDGAR |
| SC 13G/A | 2024-02-05 | Sumitomo Mitsui Trust Holdings, Inc. | Arcturus Therapeutics Holdings Inc. | 1,320,652 | 4.9% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Arcturus Therapeutics Holdings Inc. | 2,047,687 | 7.7% | EDGAR |
| SC 13G/A | 2024-01-25 | STATE STREET CORP | Arcturus Therapeutics Holdings Inc. | - | 6.1% | EDGAR |
| SC 13G/A | 2024-01-25 | BlackRock Inc. | Arcturus Therapeutics Holdings Inc. | 2,398,296 | 9.0% | EDGAR |
| SC 13G/A | 2024-01-17 | FEDERATED HERMES, INC. | Arcturus Therapeutics Holdings Inc. | 4,711,512 | 17.6% | EDGAR |
| SC 13G/A | 2023-10-10 | STATE STREET CORP | Arcturus Therapeutics Holdings Inc. | - | 6.3% | EDGAR |
| SC 13G/A | 2023-02-10 | ARK Investment Management LLC | Arcturus Therapeutics Holdings Inc. | 2,012,429 | 7.6% | EDGAR |
| SC 13G/A | 2023-02-10 | Nikko Asset Management Americas, Inc. | Arcturus Therapeutics Holdings Inc. | 1,449,060 | 5.4% | EDGAR |
| SC 13G | 2023-02-09 | VANGUARD GROUP INC | Arcturus Therapeutics Holdings Inc. | 1,450,425 | 5.5% | EDGAR |
| SC 13G/A | 2023-02-08 | STATE STREET CORP | Arcturus Therapeutics Holdings Inc. | - | 8.5% | EDGAR |
| SC 13G/A | 2023-02-03 | Sumitomo Mitsui Trust Holdings, Inc. | Arcturus Therapeutics Holdings Inc. | 1,449,060 | 5.4% | EDGAR |
| SC 13G/A | 2023-02-01 | FEDERATED HERMES, INC. | Arcturus Therapeutics Holdings Inc. | 4,239,554 | 16.0% | EDGAR |
| SC 13G/A | 2023-01-31 | BlackRock Inc. | Arcturus Therapeutics Holdings Inc. | 1,884,885 | 7.1% | EDGAR |
| SC 13G/A | 2022-04-11 | STATE STREET CORP | Arcturus Therapeutics Holdings Inc. | - | 12.2% | EDGAR |
| SC 13G | 2022-02-15 | Arcturus Therapeutics Holdings Inc. | Vallon Pharmaceuticals, Inc. | - | - | EDGAR |
| SC 13G/A | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Arcturus Therapeutics Holdings Inc. | 15,039 | 0.0% | EDGAR |
| SC 13G | 2022-02-14 | Nikko Asset Management Americas, Inc. | Arcturus Therapeutics Holdings Inc. | 1,357,472 | 5.2% | EDGAR |